| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.089 | 0.03 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.065 | 0.03 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |